Squalamine-Press Release, Magainin Pharmaceuticals

An edge with squalamine ------------------------ Magainin Pharmaceuticals of Plymouth Meeting, Pa., said that 11 of 36 patients (31%) with Stage IIIb and IV non-small-cell lung cancer in a phase-2a trial responded with partial responses to squalamine given in combination with carboplatin and paclitaxel.

This compares with a 15% historical response rate to chemotherapy alone, according to the company.

Squalamine is an anti-angiogenic aminosterol, a class of small molecules discovered in the dogfish shark, that is also being investigated for ovarian cancer, prostate cancer, pediatric solid tumors, brain tumors, and fibrodysplasia ossificans progressiva.

Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.